Asia-Pacific accounts for over 30% of global clinical trial activity and is growing faster than any other region. ClinTrust.ai is headquartered in Singapore and designed from the ground up for APAC's regulatory, banking, and operational realities.
Singapore sits at the center of Asia-Pacific's clinical research ecosystem — geographically, regulatory, and financially. As the region's leading financial hub with advanced payment infrastructure, robust clinical research regulation, and deep talent depth in life sciences and fintech, Singapore is the natural home base for a clinical trial payment infrastructure business.